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Introduction
In patients with end-stage renal failure, vascular ac-
cess remains the Achilles’ heel of maintenance haemo-
dialysis. Successful haemodialysis requires repetitive
access to large vessels that are capable of providing
rapid extracorporeal blood flow. The primary arterio-
venous fistula (AVF), created by an anastomosis
of the radial artery with the cephalic vein, was first
described by Brescia et al in 1966.1 The cephalic
vein becomes arterialised and will theoretically stay
uncollapsed even when blood is drawn from it at high
flow-rates. Throughout the past decades, this technique
has remained the preferred mode of achieving vascu-
lar access during haemodialysis.
Maintaining patent vascular access remains a ma-
jor challenge, especially in an ageing haemodialysis
population. Cumulative data shows that vascular ac-
cess is lost predominantly from an inability to resolve
a thrombotic episode.2 Over 85% of the documented
episodes of thrombosis have an anatomical cause, the
most common being stenotic lesions at the arterio-
venous anastomosis or along the proximal venous limb.
Prospective detection and preventive treatment of a
high-grade venous stenosis are important, since they
will improve the patency of vascular access and hence
decrease the incidence of haemodialysis failure due to
fistula loss. Percutaneous transluminal angioplasty
(PTA) has been gaining favour in recent years as a
means of correcting venous stenosis, thereby improv-
ing fistula function and prolonging fistula survival. The
majority of the available data on this form of treat-
ment, however, has come from Caucasian patients.
This article reviews the clinical course and treat-
ment outcome of performing PTA for AVF stenosis
among Chinese patients on maintenance haemodialy-
sis. Two patients with different problems and outcomes
will be highlighted.
Subjects and methods
Subjects
Patients on maintenance haemodialysis who under-
went PTA between 1993 and 1996 at the Queen Mary
Hospital were reviewed. Clinical suspicion of AVF
stenosis was based upon abnormal dialysis blood line
pressures. Venous dialysis pressures were measured
with a mechanical electrical strain gauge and read from
the venous pressure monitor of a Gambro AK-10 or
similar haemodialysis machine (Gambro Inc., Lincoln-
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shire, Illinois, USA). Venous dialysis pressures were
measured for the first 30 minutes of each treatment
session, while the extracorporeal blood flow through
a standard 16 gauge needle was 100 to 150 mL/min.
Under such conditions, venous pressures of more than
100 mm Hg, if recorded on three consecutive occa-
sions, were considered abnormal. The arterial blood
flow was then increased to the maximum rate. Arterial
inflow pressures were reflected indirectly from an air
cushion situated between the arterial blood line and
the blood pump.
Patients with abnormal dialysis pressures under-
went an elective diagnostic venogram (fistulogram).
Briefly, patients were admitted as day-cases for
fistulograms. A 16 gauge needle was inserted and se-
cured pointing towards the AVF anastomosis. With a
sphygmomanometer cuff applied to the upper arm
and inflated to above the diastolic blood pressure, 20
to 30 mL of Iopamiro (iopamidol; Bracco, Milan, Italy)
were administered using an automated injection gun
at a rate of 200 mL/min while fistulograms were taken
in rapid succession. This was followed by flushing with
normal saline to alleviate any local discomfort in the
forearm. The entire procedure was sometimes repeated
without the sphygmomanometer cuff to visualise the
more proximal venous run-off.
Angioplasty technique
A 6-French vascular introducer sheath was inserted
percutaneously into the venous limb of the AVF, and
was directed retrogradely towards the stenotic segment
to be dilated. A set of diagnostic fistulograms was
produced. The length and diameter of the stenotic
segment was measured using the radiograph of the
fistulogram. An angioplasty balloon with a diameter
that was 1 mm larger than the adjacent normal vascu-
lar segment (usually 5 to 6 mm in diameter) was se-
lected for PTA. The stenosis was traversed with a
0.035-inch guide-wire (Terumo, Tokyo, Japan) via the
introducer sheath. Three thousand units of heparin were
administered through the side port of the introducer
sheath into the AVF. The selected balloon catheter was
then inserted across the stenosis using the guide-wire;
this was assisted by fluoroscopy. The balloon was in-
flated with a pressure inflation syringe until it opened
up fully (ie until the waist of the stenosis impinged on
the balloon). Inflation was sustained for 60 seconds
and the process was repeated two or three times.
Heparin infusion was started immediately for 24 hours
followed by oral aspirin 150 mg/day as maintenance
prophylaxis against thrombosis.
After PTA, a set of arteriovenous fistulograms
was again performed to document the result of the
angioplasty. The PTA was considered technically
successful if the degree of residual stenosis was
less than 30% as visualised using the fistulogram. A
clinically successful PTA procedure was defined as a
reduction of venous dialysis pressure to less than 100
mm Hg (for venous stenoses) and/or a reduction of
arterial inflow (negative) pressure to less than 75 mm
Hg while maintaining a dialysis blood flow rate of more
than 150 mL/min.
Results
Eleven patients (eight men, three women; mean age,
43.0±11.5 years; duration on haemodialysis, 50 months
[median, 18 months]) underwent a total of 12 PTA
procedures for symptomatic stenosis of their AVF
as shown on their fistulogram. The mean follow-up
duration was 15.2±11.4 months (range, 2-42 months).
The sites of stenosis and their treatment outcome are
shown in the Table.
Seven anastomotic and five venous stenotic lesions
were detected among the 11 patients who were all
receiving maintenance haemodialysis via a native
AVF in their forearms. They presented with abnormal
dialysis pressures with physical evidence of stenosis.
Four had elevated venous dialysis pressures, six had
low arterial inflow pressures, while one (patient H)
had both abnormal venous dialysis and arterial inflow
pressures. Conclusions relating to recirculation could
not be made since recirculation was not routinely
tested. Nine of the 11 patients received a Doppler
ultrasound scan which showed areas of turbulent
blood flow in the AVF, suggestive of the presence of
stenosis. All 11 patients underwent a fistulogram to
delineate the exact anatomical location of the steno-
sis. No correlation was found between the presence of
stenosis and any of the demographic characteristics of
the patients such as age, sex, or duration on dialysis.
Percutaneous transluminal angioplasty performed
in eight patients (73%) was deemed to have both tech-
nical and clinical success (as defined in the Methods).
One of these patients (patient G) had an apparently
successful procedure but developed thrombosis 1
month later; another (patient I) had a technically but
not clinically successful PTA. Two patients (patients
D and H) had fistula thrombosis almost immediately
after the procedure and required surgical revision.
Apart from acute fistula thrombosis as described, none
of the patients displayed any major complications from
the procedure.Two patients had different problems and
treatment outcomes.
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Table. Sites of stenosis and treatment outcome
Patient Sex/age Underlying Duration on haemo- Site of Outcome
(years) disease dialysis before PTA* stenosis
(months)
A M/19 Chronic glomerulo- 22 A† Successful
nephritis
B M/46 PKD‡ 2 V§ Successful; recurrent stenosis
9 months later; had another
successful PTA
C M/44 HSPxx 129 A Successful
D M/38 IgA nephropathy 136 V Acute thrombosis
E M/41 FSGS¶ 6 A Successful
F M/55 Chronic glomerulo- 43 V Successful; thrombosis 28 months
nephritis later
G F/31 Lupus nephritis 8 A Successful; thrombosis 1 month
later
H F/54 Unknown 180 V Acute thrombosis; surgical revision
needed
I F/58 Diabetes mellitus 18 A & V Technical success; clinical failure
J M/48 Diabetes mellitus 4 A Successful
K M/36 Unknown 5 A Successful
*PTA percutaneous transluminal angioplasty
†A anastomotic lesion or lesions close to the anastomosis, distal to the arterial needle
‡PKD polycystic kidney disease
§V stenosis along the venous limb
xx HSP Henoch-Schönlein purpura
¶FSGS focal sclerosing glomerulonephritis
Patient A
A 19-year-old young man with chronic glomerulo-
nephritis had been receiving haemodialysis via an
AVF in his left forearm since 1994. In March 1996, he
was found to have a poor arterial inflow of 125 mm Hg
(acceptable limit, <75 mm Hg). The fistulogram revealed
90% stenosis just distal to the anastomosis (Fig 1);
PTA was carried out 1 week later and was considered
technically and clinically successful (Fig 1). The patient
recovered satisfactory AVF haemodynamics and did not
develop any further problems with haemodialysis.
Patient B
A 46-year-old man who had polycystic kidneys started
maintenance haemodialysis via an AVF that had been
created in his left forearm since 1995. Two months
later, he had high venous dialysis pressure (150-200
mm Hg; acceptable limit, <100 mm Hg). A long seg-
ment of narrowing that resembled a chain of beads was
demonstrated in the venous limb on the fistulogram
(Fig 2). Percutaneous transluminal angioplasty was car-
ried out by placing the angioplasty balloon at contigu-
ous locations so that the entire length of the stenosed
segment was dilated. There was a satisfactory techni-
cal and clinical outcome. The lesions recurred 9 months
later, and the patient underwent a second successful PTA.
Discussion
Establishing and maintaining vascular access in haemo-
dialysis patients are important prognostic factors
for patient survival. Indeed, the loss of vascular access
remains one of the most challenging problems con-
fronting nephrologists. Stenotic lesions of native and
synthetic fistulae are the most common anatomical
causes of thrombosis and account for approximately
85% of cases of fistula dysfunction.2 In a small per-
centage of cases, thrombosis is caused by hypotension,
inadvertent external compression, trauma, or infection.
The prospective identification and correction of
stenoses are of great importance in decreasing fistula
thrombosis rates.3 Only by doing this can fistula func-
tion and longevity be maintained. Methods to detect
high-grade stenoses include the use of clinical indica-
tors,4 the objective measurement of venous dialysis
pressure3 and urea/non-urea recirculation,5 and colour
Doppler ultrasonography.6
Venous stenoses have traditionally been corrected
surgically, but this extends the fistula further up the
involved extremity, thereby minimising future vascu-
lar access sites. Transcatheter techniques have, in
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Fig 1. Fistulograms showing various stages of percutaneous transluminal angioplasty: patient A
(1a) balloon dilatation of a stenosis (large arrow) which was adjacent to the arteriovenous fistula (small arrow); (1b) balloon
inflation with a ‘waist’ (impression cast on balloon by stenosis) [arrow] at the stenotic site; (1c) balloon inflation with the waist
fully opened up; (1d) removal of stenosis after angioplasty
1d.
1b. 1c.
1a.
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recent years, made it possible to treat these lesions
percutaneously, and PTA is an excellent means of
correcting venous stenosis in both native and synthetic
fistulae.7 It has the advantages of being a shorter
procedure than surgery, inciting less stress and discom-
fort to patients, obviating the need for prolonged
hospitalisation, having a lower chance of infection,
sparing the patient’s veins, and, in selected cases,
enabling immediate dialysis without the need for a
temporary central venous catheter.
The pathogenesis of venous stenosis is not fully
understood. Stenoses are produced by neo-intimal
proliferation, which has been attributed to the effects
of elevated venous pressure and turbulent blood flow.8,9
Turmel-Rodrigues et al10 reported that two thirds of
stenoses occur distal to the arterial needle in the
anastomotic area, while the remaining third occurs in
the venous limb proximal to the arterial needle. In our
series, anastomotic stenoses account for about 58%
(7 of 12) of the lesions; this contrasts with synthetic
arteriovenous grafts, where most of the lesions are at
the venous anastomosis (Table). The success rate of
PTA varies in different centres. In general, the cumu-
lative primary patency is in the range of 70% to 80%,
40% to 60%, and 30% to 40% at 3, 6, and 12 months,
respectively.7,11 Although PTA and surgery have com-
parable initial success rates, recurrence is invariably
more frequent after the former.3,7 Multiple PTA proce-
dures, however, are possible upon a single lesion in a
given fistula, thereby prolonging its life span without
extension of the fistula further up the arm.
Complications arising from PTA are rare. In one
series10 involving 147 PTA procedures, the overall
morbidity was 4.8% with one immediate rupture, four
delayed pseudo-aneurysms, and two patients with peri-
procedural bacteraemia. In contrast, the most common
complication in our series was immediate loss of
access due to acute thrombosis, despite the intra-
operative delivery of heparin followed by its infusion
postoperatively and the use of antiplatelet prophylaxis.
In fact, despite years of research, there is currently no
consensus with regard to the use of anticoagulation
prophylaxis for PTA. While most centres would ad-
minister heparin 2000 to 4000 U intravenously during
PTA procedures, the long-term use of antiplatelet agents
such as low-dose aspirin or sulphinpyrazone has been
favoured by only some,12 and disputed by others.13
In conclusion, this study confirms the efficacy of
PTA in the treatment of vascular access stenosis in the
Fig 2. Fistulograms showing various stages of percutaneous transluminal angioplasty: patient B
(2a) balloon dilatation of a stenotic segment (arrow) on the venous limb of a dialysis fistula; (2b) removal of stenosis after
angioplasty
2b.
2a.
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local haemodialysis population. Elevated dialysis blood
line pressure can be the first sign of fistula stenosis.
Although our series is small, we have nevertheless
demonstrated that the concerted efforts of nephro-
logists, interventional radiologists, and surgeons are
the key to maintaining and prolonging vascular access
survival in this group of patients.
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